Themis Medicare Share Price
Start SIP in Themis Medicare
Start SIPThemis Medicare Performance
Day Range
- Low 252
- High 274
52 Week Range
- Low 142
- High 303
- Open Price273
- Previous Close271
- Volume176314
Themis Medicare Investment Rating
-
Master Rating:
-
Themis Medicare has an operating revenue of Rs. 408.11 Cr. on a trailing 12-month basis. An annual revenue growth of 6% is not great, Pre-tax margin of 9% is okay, ROE of 11% is good. The company has a reasonable debt to equity of 7%, which signals a healthy balance sheet. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 44% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 73 which is a FAIR score but needs to improve its earnings, a RS Rating of 66 which is FAIR indicating the recent price performance, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 38 indicates it belongs to a strong industry group of Medical-Generic Drugs and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock definitely has some strength, you may want to examine it in more detail.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|---|---|---|
| Oper Rev Qtr Cr | 106 | 98 | 83 | 105 | 97 | 80 |
| Operating Expenses Qtr Cr | 77 | 89 | 74 | 92 | 75 | 70 |
| Operating Profit Qtr Cr | 29 | 9 | 8 | 12 | 22 | 10 |
| Depreciation Qtr Cr | 1 | 3 | 3 | 3 | 3 | 3 |
| Interest Qtr Cr | 1 | 2 | 3 | 2 | 2 | 3 |
| Tax Qtr Cr | 7 | 2 | 1 | 3 | 4 | 2 |
| Net Profit Qtr Cr | 19 | 3 | 2 | 7 | 13 | 6 |
Themis Medicare Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 5
- Bearish Moving Average
- ___
- 11
- 20 Day
- ₹270.22
- 50 Day
- ₹258.66
- 100 Day
- ₹245.02
- 200 Day
- ₹226.17
- 20 Day
- ₹270.93
- 50 Day
- ₹258.74
- 100 Day
- ₹237.41
- 200 Day
- ₹228.98
Themis Medicare Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 268.07 |
| Second Resistance | 281.98 |
| Third Resistance | 289.97 |
| RSI | 44.25 |
| MFI | 71.05 |
| MACD Single Line | 7.05 |
| MACD | 4.66 |
| Support | |
|---|---|
| First Support | 246.17 |
| Second Support | 238.18 |
| Third Supoort | 224.27 |
Themis Medicare Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 196,313 | 9,423,024 | 48 |
| Week | 271,623 | 16,631,446 | 61.23 |
| 1 Month | 588,733 | 26,233,951 | 44.56 |
| 6 Month | 187,142 | 9,012,783 | 48.16 |
Themis Medicare Result Highlights
Themis Medicare Synopsis
NSE-Medical-Generic Drugs
Themis Medicare Ltd. is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 381.76 Cr. and Equity Capital is Rs. 9.20 Cr. for the Year ended 31/03/2024. Themis Medicare Ltd. is a Public Limited Listed company incorporated on 31/05/1969 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24110GJ1969PLC001590 and registration number is 001590.| Market Cap | 2,497 |
| Sales | 391 |
| Shares in Float | 3.04 |
| No of funds | 10 |
| Yield | 0.18 |
| Book Value | 8.29 |
| U/D Vol ratio | 2.3 |
| LTDebt / Equity | 9 |
| Alpha | 0.42 |
| Beta | 1.91 |
Themis Medicare Shareholding Pattern
| Owner Name | Jun-24 | Mar-24 | Dec-23 | Sep-23 |
|---|---|---|---|---|
| Promoters | 67.15% | 67.15% | 67.16% | 67.16% |
| Mutual Funds | ||||
| Foreign Portfolio Investors | 0.05% | 0.03% | 0.01% | 0.05% |
| Financial Institutions/ Banks | 0.01% | 0.01% | 0.01% | 0.01% |
| Individual Investors | 23.42% | 23.31% | 22.67% | 22.32% |
| Others | 9.37% | 9.5% | 10.15% | 10.46% |
Themis Medicare Management
| Name | Designation |
|---|---|
| Dr. Dinesh S Patel | Chairman & Executive Director |
| Dr. Sachin D Patel | Managing Director & CEO |
| Mr. Rajneesh Anand | Non Executive Director |
| Dr. Adam Demeter | Non Executive Director |
| Mr. Hariharan Subramaniam | Independent Director |
| Ms. Manjul Sandhu | Independent Director |
| Mr. Bhaskar V Iyer | Independent Director |
| Mr. Shishir Dalal | Independent Director |
| Mrs. Reena S Patel | Alternate Director |
Themis Medicare Forecast
Price Estimates
Themis Medicare Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2024-07-26 | Quarterly Results | |
| 2024-05-14 | Audited Results & Final Dividend | |
| 2024-02-10 | Quarterly Results | |
| 2023-11-04 | Quarterly Results | |
| 2023-08-10 | Quarterly Results | (Revised) per share(17.5%)Final Dividend |
| Date | Purpose | Remarks |
|---|---|---|
| 2023-10-10 | Split | Rs.0.00 split from Rs. 10/- to Re. 1/-. |
Themis Medicare FAQs
What is Share Price of Themis Medicare ?
Themis Medicare share price is ₹254 As on 07 October, 2024 | 23:21
What is the Market Cap of Themis Medicare ?
The Market Cap of Themis Medicare is ₹2339.2 Cr As on 07 October, 2024 | 23:21
What is the P/E ratio of Themis Medicare ?
The P/E ratio of Themis Medicare is 46.8 As on 07 October, 2024 | 23:21
What is the PB ratio of Themis Medicare ?
The PB ratio of Themis Medicare is 6.2 As on 07 October, 2024 | 23:21
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.